Dr Reddys Laboratories (RDY) Inventory (2009 - 2026)

Dr Reddys Laboratories (RDY) has reported Inventory for 18 consecutive years, with $816.0 million the latest figure, recorded in Q1 2026.

• Quarterly Inventory fell 1.92% year-over-year to $816.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $816.0 million (down 1.92% YoY) and the FY2026 annual result came in at $816.0 million, down 1.92% from the prior year.
• Inventory eased to $816.0 million in Q1 2026 per RDY's latest filing, from $832.0 million in the prior quarter.
• Over the last five years, Inventory for RDY reached as high as $832.0 million in Q1 2025 and fell as low as $593.0 million in Q1 2023.
• A 5-year average of $706.4 million and a median of $671.0 million in 2022 frame the typical range for Inventory.
• Annual changes were most pronounced in 2023 — Inventory fell 11.62% — and 2024, when it climbed 28.67%.
• Year by year, Inventory stood at $631.0 million in 2022, then gained by 1.27% to $639.0 million in 2023, then increased by 19.41% to $763.0 million in 2024, then advanced by 9.04% to $832.0 million in 2025, then slipped by 1.92% to $816.0 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $816.0 million, $832.0 million, and $763.0 million for Q1 2026, Q1 2025, and Q1 2024 respectively.